Ansa Biotechnologies
Next-generation DNA synthesis using enzymes
Y Combinator — Backed by Y Combinator H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.biotechhealthcare
Company facts
Early-stage
- Founded
- 2022
- Employees
- 72
- Headquarters
- United States
- Type
- Private
About
Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach promises to dramatically accelerate innovation in biological research and biotechnology, including therapeutics, diagnostics and biomanufacturing.
2 jobs